+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Burn Ointment Market By Depth of Burn, By Product, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5241320
  • Report
  • January 2021
  • Region: Europe
  • 82 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Cipla Limited
  • ConvaTec Group PLC
  • Dr. Morepen Limited
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Mankind Pharma Ltd.
The Europe Burn Ointment Market is expected to witness market growth of 5.3% CAGR during the forecast period (2020-2026).

Increasing awareness among people about the obtainability of various treatment methods is one of the major factor that contribute to the growth of the burn ointment market. With time, consumers spending on more for better care in case of blaze accidents due to favorable reimbursements from medicare programs. Patients are concentrating on buying advanced products for the treatment bounds caused by burning. Numerous burn ointments are available in the market such as topical antibiotics, silver, and iodine-based.

To prevent the risk of hospital-acquired infection (HAI) in patients, companies involved in manufacturing healthcare products including burn injury treatment are bringing improved silver sulfadiazine (SSD) creams that minimize complications and other health risks. Healthcare professionals are in the hunt for the expertise of scientists and researchers to do an experiment on silver-containing dressings with honey, since honey offers antiseptic effects that cause faster healing of burn injuries. Healthcare companies are focused to increase their research on dressings infused with sodium hypochlorite that may give faster healing results if compared to SSD dressings.

Based on Depth of Burn, the market is segmented into Minor Burns, Partial Thickness Burns and Full Thickness Burns. Based on Product, the market is segmented into Topical Antibiotics, Silver, Iodine and Other Products. Based on End Use, the market is segmented into Clinics, Hospitals and Other End Use. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.

Scope of the Study

Market Segments covered in the Report:

By Depth of Burn
  • Minor Burns
  • Partial Thickness Burns
  • Full Thickness Burns
By Product
  • Topical Antibiotics
  • Silver
  • Iodine
  • Other Products
By End Use
  • Clinics
  • Hospitals
  • Other End Use
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Johnson and Johnson
  • ConvaTec Group PLC
  • Smith & Nephew PLC
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Perrigo Company PLC
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Dr. Morepen Limited
  • Mankind Pharma Ltd.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cipla Limited
  • ConvaTec Group PLC
  • Dr. Morepen Limited
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Mankind Pharma Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Burn Ointment Market, by Depth of Burn
1.4.2 Europe Burn Ointment Market, by Product
1.4.3 Europe Burn Ointment Market, by End Use
1.4.4 Europe Burn Ointment Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Burn Ointment Market by Depth of Burn
3.1 Europe Minor Burns Market by Country
3.2 Europe Partial Thickness Burns Market by Country
3.3 Europe Full Thickness Burns Market by Country

Chapter 4. Europe Burn Ointment Market by Product
4.1 Europe Topical Antibiotics Market by Country
4.2 Europe Silver Market by Country
4.3 Europe Iodine Market by Country
4.4 Europe Other Products Market by Country

Chapter 5. Europe Burn Ointment Market by End Use
5.1 Europe Clinics Burn Ointment Market by Country
5.2 Europe Hospitals Market by Country
5.3 Europe Other End Use Market by Country

Chapter 6. Europe Burn Ointment Market by Country
6.1 Germany Burn Ointment Market
6.1.1 Germany Burn Ointment Market by Depth of Burn
6.1.2 Germany Burn Ointment Market by Product
6.1.3 Germany Burn Ointment Market by End Use
6.2 UK Burn Ointment Market
6.2.1 UK Burn Ointment Market by Depth of Burn
6.2.2 UK Burn Ointment Market by Product
6.2.3 UK Burn Ointment Market by End Use
6.3 France Burn Ointment Market
6.3.1 France Burn Ointment Market by Depth of Burn
6.3.2 France Burn Ointment Market by Product
6.3.3 France Burn Ointment Market by End Use
6.4 Russia Burn Ointment Market
6.4.1 Russia Burn Ointment Market by Depth of Burn
6.4.2 Russia Burn Ointment Market by Product
6.4.3 Russia Burn Ointment Market by End Use
6.5 Spain Burn Ointment Market
6.5.1 Spain Burn Ointment Market by Depth of Burn
6.5.2 Spain Burn Ointment Market by Product
6.5.3 Spain Burn Ointment Market by End Use
6.6 Italy Burn Ointment Market
6.6.1 Italy Burn Ointment Market by Depth of Burn
6.6.2 Italy Burn Ointment Market by Product
6.6.3 Italy Burn Ointment Market by End Use
6.7 Rest of Europe Burn Ointment Market
6.7.1 Rest of Europe Burn Ointment Market by Depth of Burn
6.7.2 Rest of Europe Burn Ointment Market by Product
6.7.3 Rest of Europe Burn Ointment Market by End Use

Chapter 7. Company Profiles
7.1 Johnson and Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.2 ConvaTec Group PLC
7.2.1 Company Overview
7.2.1 Financial Analysis
7.2.2 Regional Analysis
7.2.3 Research & Development Expense
7.3 Smith & Nephew PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Recent strategies and developments:
7.5.4.1 Approvals:
7.6 Perrigo Company PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Cipla Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Dr. Morepen Limited
7.9.1 Company Overview
7.10. Mankind Pharma Ltd.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
Note: Product cover images may vary from those shown
  • Johnson and Johnson
  • ConvaTec Group PLC
  • Smith & Nephew PLC
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Perrigo Company PLC
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Dr. Morepen Limited
  • Mankind Pharma Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll